Clinical Trial Update: Protectivity and Safety Following Recombinant Hepatitis B Vaccine [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update on recombinant Hepatitis B vaccine focusing on immunogenicity and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Recombinant hepatitis B vaccine (hepatitis B vaccine, recombinant)

Snippet

Sponsor: PT Bio Farma | Conditions: Immunogenicity | Phase 2, Phase 3 | Status: COMPLETED